Nome Químico: (2R,5R)-2,5-dimethyl-1-propyl-3-(o-tolyl)imidazolidin-4-one
Sorrisos: CC1=CC=CC=C1N2[C@H](C)N(CCC)[C@H](C)C2=O
Inchi: InChI=1S/C23H30O6/c1-13(24)28-12-18(26)22(27)9-7-16-17-5-4-14-10-15(25)6-8-20(14,2)23(17)19(29-23)11-21(16,22)3/h10,16-17,19,27H,4-9,11-12H2,1-3H3/t16?,17?,19-,20-,21-,22-,23+/m0/s1
Liquid–Liquid Miscibility Gaps in Drug–Water Binary Systems: Crystal Structure and Thermodynamic Properties of Prilocaine and the Temperature–Composition Phase Diagram of the Prilocaine–Water System
Ivo B. Rietveld, Marc-Antoine Perrin, Siro Toscani, Maria Barrio, Beatrice Nicolai, Josep-Lluis Tamarit, and René Ceolin
Mol. Pharmaceutics 2013, 10, 4, 1332–1339
LC Determination of Lidocaine and Prilocaine Containing Potential Risky Impurities and Application to Pharmaceuticals
Mohammad Abdul-Azim Mohammad
Chromatographia volume 70, pages563–568(2009)
Determination of prilocaine HCL in bulk drug and pharmaceutical formulation by GC-NPD method
alptug atila, yucel kadioglu
Chemical Industry and Chemical Engineering Quarterly 19(2)
Simultaneous quantification of lidocaine and prilocaine in human plasma by LC-MS/MS and its application in a human pharmacokinetic study
Siva SankaraRao, Yadlapalli, Naresh KumarKatari, Surendra Babu, Manabolu Surya, Vijaya KumariKarra, VinuthaKommineni, Sreekantha B.Jonnalagadda
Practical Laboratory Medicine Volume 17, November 2019, e00129
